Inventor
KEHLER JAN
DK65 patents
⚠️ This page may combine multiple inventors who share the name “KEHLER JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
29 patentsUS10034861B2Jul 31, 2018
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS13 citations92
US11026923B2Jun 8, 2021
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS4 citations84
US11026924B2Jun 8, 2021
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS4 citations84
US10806718B2Oct 20, 2020
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS7 citations84
US10689379B2Jun 23, 2020
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
H LUNDBECK AS6 citations84
US10618913B2Apr 14, 2020
Macrocycles as PDE1 inhibitors
H LUNDBECK AS7 citations84
US10512632B2Dec 24, 2019
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors
H LUNDBECK AS9 citations84
US10011606B2Jul 3, 2018
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS8 citations84
US10351561B2Jul 16, 2019
Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors
H LUNDBECK AS12 citations83
US11491140B2Nov 8, 2022
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10858362B2Dec 8, 2020
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10766893B2Sep 8, 2020
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
H LUNDBECK AS6 citations73
US10633382B2Apr 28, 2020
Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors
H LUNDBECK AS2 citations73
US10538525B2Jan 21, 2020
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
H LUNDBECK AS5 citations73
US10150771B2Dec 11, 2018
Triazolopyrazinones as PDE1 inhibitors
H LUNDBECK AS7 citations73
US9718832B2Aug 1, 2017
Hexahydrofuropyrroles as PDE1 inhibitors
H LUNDBECK AS2 citations73
US9701665B2Jul 11, 2017
Quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS3 citations73
US11535611B2Dec 27, 2022
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
H LUNDBECK AS1 citations62
US11472810B2Oct 18, 2022
Imidazopyrazinones as PDE1 inhibitors
H LUNDBECK AS0 citations62
US11104680B2Aug 31, 2021
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
H LUNDBECK AS1 citations62
US10912773B2Feb 9, 2021
Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations62
US10905688B2Feb 2, 2021
Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors
H LUNDBECK AS2 citations62
US11851425B2Dec 26, 2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines
H LUNDBECK AS0 citations52
US11634416B2Apr 25, 2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines
H LUNDBECK AS0 citations52
US10526319B2Jan 7, 2020
Halogenated quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS0 citations52
US10030007B2Jul 24, 2018
Quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS0 citations52
US10005764B2Jun 26, 2018
Halogenated quinazolin-THF-amines as PDE1 inhibitors
H LUNDBECK AS1 citations52
US9801878B2Oct 31, 2017
Quinoline derivatives as PDE10A enzyme inhibitors
H LUNDBECK AS0 citations51
US9669029B2Jun 6, 2017
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
H LUNDBECK AS0 citations51
LUNDBECK & CO AS H
15 patentsUS7223765B2May 29, 2007
4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
LUNDBECK & CO AS H2 citations63
US7074796B2Jul 11, 2006
4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
LUNDBECK & CO AS H3 citations63
US9018217B2Apr 28, 2015
Phenylimidazole derivatives as PDE10A enzyme inhibitors
LUNDBECK & CO AS H1 citations60
US7737171B2Jun 15, 2010
Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
LUNDBECK & CO AS H1 citations60
US7737170B2Jun 15, 2010
Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
LUNDBECK & CO AS H1 citations60
US7351734B2Apr 1, 2008
Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
LUNDBECK & CO AS H2 citations60
US7678800B2Mar 16, 2010
2-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence
LUNDBECK & CO AS H2 citations59
US7652150B2Jan 26, 2010
2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIs
LUNDBECK & CO AS H1 citations59
US7834008B2Nov 16, 2010
Cyclopropyl derivatives as NK3 receptor antagonists
LUNDBECK & CO AS H5 citations58
US9062060B2Jun 23, 2015
Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors
LUNDBECK & CO AS H0 citations52
US8796304B2Aug 5, 2014
Tricyclic imidazole compounds as PDE10 inhibitors
LUNDBECK & CO AS H0 citations52
US7276508B2Oct 2, 2007
Indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US7105543B2Sep 12, 2006
4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US6958338B2Oct 25, 2005
4-,5-,6-and 7-indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US6890916B2May 10, 2005
Indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
RITZÉN ANDREAS
2 patentsRITZEN ANDREAS
1 patentSIMONSEN KLAUS BAEK
1 patentKEHLER JAN
1 patentPUESCHL ASK
1 patentShowing the top 50 of 65 patents by PatentIndex Score.